GDF15 and metabolic dysfunction-associated steatotic liver disease: Given the close correlation between obesity and MASLD, the liver could be a contributing tissue for the elevated circulating levels of GDF15, which could explain the positive correlations observed in this study between circulating GDF15 levels and various hepatic markers, such as alkaline phosphatase and transaminases.